SNTI.US Senti Biosciences Inc

Healthcare Biotechnology USA Stocks
0.1056 USD
Close of Nov 17, 2026
0.0900 2.48
Market cap
USD 4.06M
P/E
-
P/B
5.45x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SNTI.US undervalued?

Graham number

The Graham number of Senti Biosciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Senti Biosciences Inc fundamental analysis

No fundamental analysis for Senti Biosciences Inc yet.

Senti Biosciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Senti Biosciences Inc

Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-202, a logic gated off-the-sh…

Full company profile